Medical device licence · 6229 · Class 2
BBL C-REACTIVE PROTEIN TEST
No longer licensed: discontinued at renewal
Licence status Discontinued at renewal; first licensed June 24, 1999; ended October 30, 2002. It is in Health Canada’s archive of licences no longer in force.
- Licence number
- 6229
- Licence holder
- Becton Dickinson Diagnostic Instrument SystemsSparks, MD, United States
- Risk class
- Class II (low to moderate risk)
- Licence type
- Test Kit
- First licensed
- June 24, 1999
- Ended
- October 30, 2002
- Devices covered
- 3
Devices on this licence
By name, as listed. The official record lists model numbers and identifiers.
- BBL* C-REACTIVE PROTEIN ANTISERUM
- BBL* C-REACTIVE PROTEIN CONTROL SERUM
- BBL* C-REACTIVE PROTEIN TEST
Class I devices, the lowest-risk group, mostly need no device licence, so most are not in this list.